Celecoxib, another specific inhibitor of COX2, ameliorated rat liver fibrosis induced by thioacetamide (TAA) by decreasing intrahepatic and intestinal lipopolysaccharide (LPS) levels [9]. This evidence concerns the gene PTGS2 and Hepatic fibrosis.